Company Active LTD

Company profile

Mast Group Limited

Mast Group Home Page

Mast Group Ltd. is an independent world class manufacturer and supplier of diagnostic products for clinical, industrial and veterinary testing.

CRN
00632512
Founded
1959
Age
66

Overview

Legal name
MAST GROUP LIMITED
Region
Unknown
Registered address
MAST HOUSE
DERBY ROAD
LIVERPOOL
L20 1EA
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

Mast Group Limited
No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

6 events
16 Mar
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Jun
2026

Accounts due

Accounts Due

Next accounts due date

02 Mar
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

18 Oct
2024

Accounts With Accounts Type Group

Accounts PDF pending

AA | Transaction MzQ0MDA1NjAyNGFkaXF6a2N4 | Paper/PDF filed

Published 20 Oct 2024 06:18

30 Sep
2024

Accounts filed

Accounts

Last accounts made up date

10 Jul
1959

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2010
Funded years
2010, 2012
Age at first award
51 years

Projects

2012 Collaborative R&D Lead participant

A rapid near patient testing system for the detection of microbial pathogens in blood

1 Nov 2012 to 31 Oct 2015

Awarded
£232,058
Total cost £840,182

The detection and diagnosis of healthcare associated infections in the critical care environment is extremely challenging. In the UK alone, there are over 42,000 HCAI sepsis episodes annually. Existing culture tests lack the sensitivity and speed necessary to effect time-critical, life-saving clinical decisions needed for safe and personalised patient car...

2010 Collaborative R&D Lead participant

A rapid cost-effective and highly sensitive point of care platform for detection of Chlamydia and Gonorrhoea

1 Oct 2010 to 30 Jun 2016

Awarded
£237,977
Total cost £1,197,672

The consortium will develop a rapid, affordable, sensitive platform for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae from urine samples. The platform will be fully integrable with LIMS (laboratory information management system). This will enable rapid point of care (POC) testing within the hospital and genitourinary medicine (GUM) clin...

Product types

Collaborative R&D